Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Operating Margin for Rigel Pharmaceuticals (RIGL)
Operating Margin as of April 2024 (TTM): -11.59%
According to Rigel Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -11.59%. At the end of 2021 the company had an Operating Margin of -11.60%.
Operating Margin history for Rigel Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -11.60% | -57.64% |
| 2020 | -27.38% | -75.73% |
| 2019 | -112.83% | -28.75% |
| 2018 | -158.35% | -90.9% |
| 2017 | -1,739.34% | 412.21% |
| 2016 | -339.58% | 90.66% |
| 2015 | -178.11% | -83.84% |
| 2014 | -1,101.92% | -11.5% |
| 2013 | -1,245.13% | -71.66% |
| 2012 | -4,392.89% | 142.71% |
| 2011 | -1,809.96% | -6071.09% |
| 2010 | 30.31% | -100.2% |
| 2009 | -14,885.33% | |
| 2007 | -631.17% | 390.79% |
| 2006 | -128.60% | -55.65% |
| 2005 | -289.98% | -75.87% |
| 2004 | -1,201.50% | 225.34% |
| 2003 | -369.31% | 57.52% |
| 2002 | -234.46% | 43.75% |
| 2001 | -163.11% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 34.59% | -398.45% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -148.58% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | -160.78% | 1,287.23% | 🇺🇸 USA |
 ChemoCentryx CCXI | -404.57% | 3,390.68% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.